A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03613077

Acronym

BLX_NIS

Enrollment

153

Registered

2018-08-02

Start date

2018-05-14

Completion date

2025-08-21

Last updated

2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Operation With Implant of Artificial Internal Device

Keywords

Survival rate, Success rate, Straumann® BLX Implant Roxolid® SLActive®,

Brief summary

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Detailed description

Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm

Interventions

PROCEDUREsurgical placement of an endosteal implant

Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients seeking an implant supported restoration * all patients with conditions that are in accordance with the IFU * Patients must provide their informed consent for study participation and must be willing and able to attend control visits * Patients need to be at least 18 years old

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Implant success rate at one year post implant placement	12 months follow-up period after implantation	Measured in percent
Implant survival rate at one year post implant placement	12 months follow-up period after implantation	Measured in percent

Secondary

Measure	Time frame	Description
Prosthetic success at 12 months post implant placement	12 months follow-up period after implantation	Measured in percent
Prosthetic survival at 12 months post implant placement	12 months follow-up period after implantation	Measured in percent

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026